tirzepatide vs semaglutide safety profile semaglutide: A new battle in obesity treatment Tirzepatide vs. Semaglutide: Which Weight

Tirzepatide is a dual GIP and GLP-1 receptor agonist with an elimination half-life of approximately 5 days

By increasing growth hormone levels, Ipamorelin helps to enhance the bodys fat-burning capabilities, allowing individuals to achieve a leaner, more toned appearance

Anything higher than this signals the need to initiate or alter therapy

Patients should continue to follow a balanced diet, exercise regularly, and maintain a healthy weight

Your healthcare provider will also consider your goals when creating a treatment plan, so having it laid out before your appointment can ensure your treatment is designed in a way that will help you achieve these goals